ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis

Novartis Pharmaceuticals · 2014
ClinicalTrials.gov · Datasets · License: Public Domain · 2014
Open Source ↗
sporadic inclusion body myositis (sibm), inclusion body myositis (ibm), interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 845102
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.